Hainan Haiyao Co Ltd Asset Resilience Ratio
Hainan Haiyao Co Ltd asset resilience ratio. Hainan Haiyao Co Ltd (000566) has an Asset Resilience Ratio of 3.27% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 000566 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Hainan Haiyao Co Ltd (1993–2024)
Asset resilience ratio of Hainan Haiyao Co Ltd from 1993 to 2024. This chart shows how Hainan Haiyao Co Ltd's Asset Resilience Ratio has changed over time. Read how much debt does Hainan Haiyao Co Ltd carry for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Hainan Haiyao Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Hainan Haiyao Co Ltd's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥189.11 Million | 3.27% |
| Total Liquid Assets | CN¥189.11 Million | 3.27% |
Asset Resilience Insights
- Limited Liquidity: Hainan Haiyao Co Ltd maintains only 3.27% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Hainan Haiyao Co Ltd Industry Peers by Asset Resilience Ratio
Compare Hainan Haiyao Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
H Lundbeck A/S
CO:HLUN-B |
Drug Manufacturers - Specialty & Generic | -0.56% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Viyash Scientific Limited
NSE:SEQUENT |
Drug Manufacturers - Specialty & Generic | 0.08% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
Hainan Haiyao Co Ltd Asset Resilience Ratio by Year (1993–2024)
Hainan Haiyao Co Ltd asset resilience ratio by year from 1993 to 2024. The table below shows the annual Asset Resilience Ratio data for Hainan Haiyao Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 3.14% | CN¥192.06 Million ≈ $28.10 Million |
CN¥6.11 Billion ≈ $894.60 Million |
-4.54pp |
| 2023-12-31 | 7.68% | CN¥566.02 Million ≈ $82.83 Million |
CN¥7.37 Billion ≈ $1.08 Billion |
-0.19pp |
| 2022-12-31 | 7.87% | CN¥580.00 Million ≈ $84.87 Million |
CN¥7.37 Billion ≈ $1.08 Billion |
-2.24pp |
| 2021-12-31 | 10.11% | CN¥845.87 Million ≈ $123.78 Million |
CN¥8.36 Billion ≈ $1.22 Billion |
-6.33pp |
| 2020-12-31 | 16.45% | CN¥1.69 Billion ≈ $247.38 Million |
CN¥10.28 Billion ≈ $1.50 Billion |
+2.11pp |
| 2019-12-31 | 14.34% | CN¥1.55 Billion ≈ $226.10 Million |
CN¥10.78 Billion ≈ $1.58 Billion |
+13.81pp |
| 2018-12-31 | 0.53% | CN¥54.27 Million ≈ $7.94 Million |
CN¥10.34 Billion ≈ $1.51 Billion |
-2.25pp |
| 2017-12-31 | 2.78% | CN¥293.17 Million ≈ $42.90 Million |
CN¥10.55 Billion ≈ $1.54 Billion |
+2.26pp |
| 2016-12-31 | 0.52% | CN¥50.37 Million ≈ $7.37 Million |
CN¥9.61 Billion ≈ $1.41 Billion |
+5.38pp |
| 2015-12-31 | -4.85% | CN¥-236.90 Million ≈ $-34.67 Million |
CN¥4.88 Billion ≈ $714.42 Million |
-5.58pp |
| 2012-12-31 | 0.72% | CN¥20.00 Million ≈ $2.93 Million |
CN¥2.76 Billion ≈ $404.10 Million |
+0.40pp |
| 2010-12-31 | 0.33% | CN¥3.52 Million ≈ $514.36K |
CN¥1.08 Billion ≈ $157.78 Million |
+0.30pp |
| 2009-12-31 | 0.03% | CN¥232.99K ≈ $34.09K |
CN¥845.06 Million ≈ $123.66 Million |
+0.01pp |
| 2008-12-31 | 0.02% | CN¥144.30K ≈ $21.12K |
CN¥734.56 Million ≈ $107.49 Million |
-2.52pp |
| 1996-12-31 | 2.54% | CN¥24.17 Million ≈ $3.54 Million |
CN¥953.11 Million ≈ $139.47 Million |
+0.84pp |
| 1995-12-31 | 1.70% | CN¥14.31 Million ≈ $2.09 Million |
CN¥844.05 Million ≈ $123.51 Million |
-5.41pp |
| 1994-12-31 | 7.10% | CN¥55.95 Million ≈ $8.19 Million |
CN¥787.46 Million ≈ $115.23 Million |
+6.34pp |
| 1993-12-31 | 0.76% | CN¥4.45 Million ≈ $650.74K |
CN¥583.44 Million ≈ $85.38 Million |
-- |
About Hainan Haiyao Co Ltd
Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company offers intermediates, active pharmaceutical ingredients (APIs), innovative chemical drugs, modern traditional Chinese medicine, biopharmaceuticals, cell immunotherapy, and medical devices, as well as big health category products, digestive and anti-infective product… Read more